Detection of the Single Hotspot Mutation in the JH2 Pseudokinase Domain of Janus Kinase 2 in Bone Marrow Trephine Biopsies Derived from Chronic Myeloproliferative Disorders

This publication has 18 references indexed in Scilit:

• The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both “atypical” myeloproliferative disorders and myelodysplastic syndromes
  Blood, 2005
• On the molecular origins of the chronic myeloproliferative disorders: it all makes sense
  Blood, 2005
• Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
  Published by Elsevier ,2005
• A Gain-of-Function Mutation ofJAK2in Myeloproliferative Disorders
  New England Journal of Medicine, 2005
• A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera
  Nature, 2005
• Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders
  Blood, 2003
• Quantitative Intra-Individual Monitoring of BCR-ABL Transcript Levels in Archival Bone Marrow Trephines of Patients with Chronic Myeloid Leukemia
  The Journal of Molecular Diagnostics, 2003
• Evolution of Myelofibrosis in Chronic Idiopathic Myelofibrosis as Evidenced in Sequential Bone Marrow Biopsy Specimens
  American Journal of Clinical Pathology, 2003
• JAKs, STATs and Src kinases in hematopoiesis
  Oncogene, 2002
• Myelofibrosis with Myeloid Metaplasia
  New England Journal of Medicine, 2000